ArticleThe oncologist2026

Association of sodium-glucose co-transport protein 2 inhibitor use with clinical outcomes in patients receiving immune checkpoint inhibitors: a pan-tumor propensity-matched analysis.

Sean C Dougherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.